DK0607777T3 - Anvendelse af leflunomid til inhibering af interleukin 8 - Google Patents

Anvendelse af leflunomid til inhibering af interleukin 8

Info

Publication number
DK0607777T3
DK0607777T3 DK94100017T DK94100017T DK0607777T3 DK 0607777 T3 DK0607777 T3 DK 0607777T3 DK 94100017 T DK94100017 T DK 94100017T DK 94100017 T DK94100017 T DK 94100017T DK 0607777 T3 DK0607777 T3 DK 0607777T3
Authority
DK
Denmark
Prior art keywords
leflunomide
inhibit interleukin
interleukin
inhibit
methylisoxazole
Prior art date
Application number
DK94100017T
Other languages
English (en)
Inventor
Klaus Ulrich Dr Weithmann
Robert Ryder Dr Bartlett
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Application granted granted Critical
Publication of DK0607777T3 publication Critical patent/DK0607777T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/275Nitriles; Isonitriles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42Oxazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
DK94100017T 1993-01-08 1994-01-03 Anvendelse af leflunomid til inhibering af interleukin 8 DK0607777T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4300278 1993-01-08

Publications (1)

Publication Number Publication Date
DK0607777T3 true DK0607777T3 (da) 1999-08-16

Family

ID=6477854

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94100017T DK0607777T3 (da) 1993-01-08 1994-01-03 Anvendelse af leflunomid til inhibering af interleukin 8

Country Status (8)

Country Link
US (1) US5547971A (da)
EP (1) EP0607777B1 (da)
JP (1) JPH06234636A (da)
AT (1) ATE174220T1 (da)
DE (1) DE59407415D1 (da)
DK (1) DK0607777T3 (da)
ES (1) ES2125356T3 (da)
GR (1) GR3029489T3 (da)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6335356B1 (en) 1994-01-07 2002-01-01 Sugen, Inc. Method of treating a patient by parenteral administration of a lipophilic compound
US5610173A (en) * 1994-01-07 1997-03-11 Sugen, Inc. Formulations for lipophilic compounds
US5700823A (en) * 1994-01-07 1997-12-23 Sugen, Inc. Treatment of platelet derived growth factor related disorders such as cancers
US5721277A (en) * 1995-04-21 1998-02-24 Sugen, Inc. Compounds and methods for inhibiting hyper-proliferative cell growth
US6331555B1 (en) 1995-06-01 2001-12-18 University Of California Treatment of platelet derived growth factor related disorders such as cancers
US6011051A (en) * 1996-07-31 2000-01-04 Hoechst Aktiengesellschaft Use of isoxazole and crotonamide derivatives for the modulation of apoptosis
US6316479B1 (en) 1997-05-19 2001-11-13 Sugen, Inc. Isoxazole-4-carboxamide compounds active against protein tryosine kinase related disorders
ES2166205T3 (es) * 1997-08-08 2002-04-01 Aventis Pharma Gmbh Forma cristalina de amida del acido n-(4-trifluorometilfenil)-5-metilisoxazol-4-carboxilico.
US7051557B2 (en) * 2002-07-18 2006-05-30 Sara Lee Corporation Hidden band brassiere, blank and methods of making same
AT412785B (de) * 2003-12-04 2005-07-25 Kungl Andreas J Dr Gag-bindungsproteine
WO2022128054A1 (en) 2020-12-14 2022-06-23 Symrise Ag Medicament for fighting inflammatory conditions of human skin (iv)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2854439A1 (de) * 1978-12-16 1980-07-03 Hoechst Ag Ein isoxazolderivat, verfahren zu seiner herstellung, diese verbindung enthaltende mittel und verwendung
DE3534440A1 (de) * 1985-09-27 1987-04-02 Hoechst Ag Arzneimittel gegen chronische graft-versus-host-krankheiten sowie gegen autoimmunerkrankungen, insbesondere systemischen lupus erythematodes
BR9008022A (pt) * 1990-05-18 1993-04-06 Hoechst Ag Amida de acido isoxazol-4-carboxilico e amidas de acido hidroxialquilideno-cianoacetico,medicamentos contendo estes compostos e sua aplicacao

Also Published As

Publication number Publication date
JPH06234636A (ja) 1994-08-23
US5547971A (en) 1996-08-20
ES2125356T3 (es) 1999-03-01
EP0607777A2 (de) 1994-07-27
GR3029489T3 (en) 1999-05-28
ATE174220T1 (de) 1998-12-15
DE59407415D1 (de) 1999-01-21
EP0607777B1 (de) 1998-12-09
EP0607777A3 (da) 1994-08-31

Similar Documents

Publication Publication Date Title
DK0607775T3 (da) Anvendelse af leflunomid til inhibering af interleukin 1 beta
ATE156482T1 (de) 1,4,5-triphenyl-pyrazolverbindungen zur behandlumg von entzündungen und entzündungsverwandten störungen
DE69334250D1 (de) Verfahren und Intermediate zur Herstellung von retroviralen Proteasehemmern
DK0607776T3 (da) Anvendelse af leflunomid til inhibering af tumornekrosefaktor alfa
DE122006000010I1 (de) Benzocyclobutyl- oder Indanyl-Alkyl-Amino-Alkyl substituierte 3- Benzazepin-2-ones, verwendbar in der Behandlung von kardiovaskularen Krankheiten
FI935778A0 (fi) HIV-proteasinhibitorer som aer anvaendbara foer behandling av AIDS
PT809636E (pt) Isoxazoles substituidos utilizaveis para o tratamento de inflamacoes
FI935585A0 (fi) Pyrrolopyrimidiner
ATE63906T1 (de) 3,5-disubstituierte 4,5-dihydroisoxazole als transglutaminasehemmer.
DK0607777T3 (da) Anvendelse af leflunomid til inhibering af interleukin 8
ES2106531T3 (es) Compuestos de dibenzoxazepina substituidos en 2, 3, 4, 5, 6, 7, 8, 9 y/o 10, composiciones farmaceuticas y metodos de uso.
DK0607774T3 (da) Anvendelse af leflunomid til inhibering af interleukin 1 alfa
DK149590C (da) Analogifremgangsmaade til fremstilling af 2-aryl-3,4-diaza-bicyclo(4,1,0)hepten-(2)-on-(5)-forbindelser
DE3864124D1 (de) Isoxazole mit nootropischer wirkung.
SE9201188D0 (sv) Ny anvaendning
DE69026991T2 (de) Phospholipide zur Behandlung der multiplen Sklerose
DE3684825D1 (de) Verwendung von n-(1-allyl-2-pyrrolidinylmethyl)-2-methoxy-4-amino-5-methylsulfamoylbenzamid zur behandlung der parkinson-krankheit.
SU1732643A1 (ru) Амиды n-этоксиоксалилантраниловой кислоты, проявляющие противовоспалительную и анальгетическую активность